CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial [Phase 2]
Summary
Phase 2 trial evaluating chlorhexidine and/or metronidazole pre-treatment with FB301 for bacterial vaginosis; recruitment has not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Freya Biosciences ApS | Conditions: Bacterial Vaginosis (BV) | Phase 2 | Status: NOT_YET_RECRUITING